145 related articles for article (PubMed ID: 34675615)
1. The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma.
Zhong G; Wang Y; Wei H; Chen M; Lin H; Huang Z; Huang J; Wang S; Lin J
Int J Gen Med; 2021; 14():6477-6485. PubMed ID: 34675615
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the expression of HER family members in primary osteosarcoma.
Wang SL; Zhong GX; Wang XW; Yu FQ; Weng DF; Wang XX; Lin JH
Oncol Lett; 2018 Aug; 16(2):2185-2194. PubMed ID: 30008917
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic value of NADPH oxidase 2 (NOX2) in primary osteosarcoma.
Lin RJ; Huang Z; Wang SL; Chen H; Wei HX; Shen RK; Yang LY; Lin JH
J Orthop Sci; 2021 May; 26(3):466-472. PubMed ID: 32402505
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of the recepteur d'origine nantais (RON) expression in primary high-grade osteosarcoma.
Wang SL; Weng DF; Wei HX; Huang Z; Lin RQ; Shi K; Lin JH
J Orthop Sci; 2021 Nov; 26(6):1100-1106. PubMed ID: 32972820
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
[TBL] [Abstract][Full Text] [Related]
7. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
8. miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy.
Dong S; Xiao Y; Ma X; He W; Kang J; Peng Z; Wang L; Li Z
Onco Targets Ther; 2019; 12():10089-10098. PubMed ID: 31819503
[TBL] [Abstract][Full Text] [Related]
9. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
10. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
11. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
[TBL] [Abstract][Full Text] [Related]
12. Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy.
Liu C; Xing Y; Wei D; Jiao Q; Yang Q; Lei D; Tao X; Yao W
Biomed Res Int; 2020; 2020():3268138. PubMed ID: 33029501
[TBL] [Abstract][Full Text] [Related]
13. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Zhao E; Zhou C; Chen S
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
[TBL] [Abstract][Full Text] [Related]
14. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
15. Gasdermin D expression and clinicopathologic outcome in primary osteosarcoma patients.
Lin R; Wei H; Wang S; Huang Z; Chen H; Zhang S; Lin J; Zhong G
Int J Clin Exp Pathol; 2020; 13(12):3149-3157. PubMed ID: 33425115
[TBL] [Abstract][Full Text] [Related]
16. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
Zhang B; Pang QJ; Zhang HJ; Yuan Y
Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.
Wang Y; Wang N; Zeng X; Sun J; Wang G; Xu H; Zhao W
Oncol Lett; 2017 May; 13(5):3057-3065. PubMed ID: 28521412
[TBL] [Abstract][Full Text] [Related]
18. Effects of different levels of TGF-β expression and tumor cell necrosis rates in osteosarcoma on the chemotherapy resistance of osteosarcoma.
Zhou L; Tang J; Hu F; Liao Y; Li R; Zhou Y; Yao Z; Geng Z; Yang Z; Zhang X; Xie L
J Bone Oncol; 2020 Aug; 23():100299. PubMed ID: 32566472
[TBL] [Abstract][Full Text] [Related]
19. SDF-1 Expression is Associated with Poor Prognosis in Osteosarcoma.
Yu D; Lv F; Zhang J; Li H
Ann Clin Lab Sci; 2016 Sep; 46(5):508-14. PubMed ID: 27650618
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel iron zinc finger protein 36 (ZFP36) for predicting the overall survival of osteosarcoma based on the Gene Expression Omnibus (GEO) database.
Song P; Xie Z; Chen C; Chen L; Wang X; Wang F; Xie X; Hong X; Wang Y; Wu X
Ann Transl Med; 2021 Oct; 9(20):1552. PubMed ID: 34790758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
